Market Cap 100.30M
Revenue (ttm) 90,000.00
Net Income (ttm) -46.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -52,100.00%
Debt to Equity Ratio 0.00
Volume 2,925,700
Avg Vol 8,514,760
Day's Range N/A - N/A
Shares Out 358.33M
Stochastic %K 45%
Beta 7.46
Analysts Hold
Price Target N/A

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
Seamlessmingler
Seamlessmingler Feb. 24 at 2:43 AM
$IXHL The pivotal phase 2/3 trial had 2 trials within this 2/3 study. So part 1 we have completed the dose finding study started in May 24 completed in June 25 120 patients 40 high dose 40 low dose 40 placebo We then submit those redults analysis for the FDA to approve the 2nd component of the 2/3 pivotal study. Total 120 patient study Where we are now..... We are awaiting the Dose and FDA feedback guidance and endpoints agreement. Phase three component is as follows 165 Take 42X at determined dose 165 take placebo 55 take dose dronabinol 55 take dose Acetazolamide Total 440 patient study. Its all clearly explained and correct that dosing began in May 2024 in the phase 2/3 560 person pivitol trial.
1 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:34 AM
$IXHL yall bull please stop bashing at Joel and stop beating up each other. I see OG bashing each other. No one here is a professional Finacial adviser. We are all guessing. Please just keep it nice and to the point. I’m sticking to this point. 👇
0 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:27 AM
$IXHL got @RhinoResurrected gave me this and I got this. In fine print what do you read. It’s in English not Vietnamese. It said “ 560 randomized, dosing started in may 2024.” Our clinical trial has a short cut P2/3 together. I don’t want to put false speculation or pump anything. I just want to be clear. It’s there in black and white. Dosing for 560 patient started in 2024. Are we waiting for P3 results. That explain why it took so long. If so then why do we still have $70 million at hand. Anyone please chime in.
1 · Reply
Crcarlson8456
Crcarlson8456 Feb. 24 at 2:14 AM
$IXHL no predictions of this or that blah blah blah. Waiting on the news from fda for both drugs that’s it. Anything else is a bonus. Any day now…. Maybe tomorrow maybe 3 weeks from now. Be interesting to see how the market reacts.
0 · Reply
RollTheDice369
RollTheDice369 Feb. 24 at 2:12 AM
$IXHL Today we talked about Joel's lack of communication. We have our opinions, but we can talk about it, which is great. This presentation reminded me of the CGTX presentation where people were waiting to see if the company would get BTD status. The CEO did not inform investors, but in a similar presentation he wrote in small print that the FDA had not granted it to them. LMAO @Santa_Claus_Trades
1 · Reply
RhinoResurrected
RhinoResurrected Feb. 24 at 2:05 AM
$IXHL well then I'm glad i picked up more before close!
0 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:02 AM
$IXHL call me stupid but it looks like P2/3 dosing on 560 patients started in may 2024. Are we just waiting for results of P3.
3 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 1:43 AM
$IXHL bulls i went to IXHL website and this is what i found P2/3 dosing on 560 patient started in May 2024 and on the bottom it said P2 data completed July 2025. I’m confuse I thought they haven’t got the patient yet or having dose any patients yet for P3. Can someone explain please. Anyone
2 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 1:10 AM
$IXHL good evening bulls I’ve got a 12 hours shift work today just got out. Did i missed this Is this new👇. Thank you very much.
1 · Reply
diagio
diagio Feb. 24 at 1:00 AM
$AMC $HOLO $NIO $GNS $IXHL Once again whenever you see words like “manipulation, naked shorts, synthetics, shills, hedgies, FTD, CTB, MM suppression, paid basher, paid bot, dark pools” or any other assorted baggie babble or pumper mumbo jumbo... it’s a clear sign the stock is a loser.
3 · Reply
Latest News on IXHL
Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

May 14, 2025, 4:14 PM EDT - 10 months ago

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?


Clarion Clinics Open for Psychedelic-Assisted Treatments

Feb 1, 2024, 7:30 AM EST - 2 years ago

Clarion Clinics Open for Psychedelic-Assisted Treatments


Seamlessmingler
Seamlessmingler Feb. 24 at 2:43 AM
$IXHL The pivotal phase 2/3 trial had 2 trials within this 2/3 study. So part 1 we have completed the dose finding study started in May 24 completed in June 25 120 patients 40 high dose 40 low dose 40 placebo We then submit those redults analysis for the FDA to approve the 2nd component of the 2/3 pivotal study. Total 120 patient study Where we are now..... We are awaiting the Dose and FDA feedback guidance and endpoints agreement. Phase three component is as follows 165 Take 42X at determined dose 165 take placebo 55 take dose dronabinol 55 take dose Acetazolamide Total 440 patient study. Its all clearly explained and correct that dosing began in May 2024 in the phase 2/3 560 person pivitol trial.
1 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:34 AM
$IXHL yall bull please stop bashing at Joel and stop beating up each other. I see OG bashing each other. No one here is a professional Finacial adviser. We are all guessing. Please just keep it nice and to the point. I’m sticking to this point. 👇
0 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:27 AM
$IXHL got @RhinoResurrected gave me this and I got this. In fine print what do you read. It’s in English not Vietnamese. It said “ 560 randomized, dosing started in may 2024.” Our clinical trial has a short cut P2/3 together. I don’t want to put false speculation or pump anything. I just want to be clear. It’s there in black and white. Dosing for 560 patient started in 2024. Are we waiting for P3 results. That explain why it took so long. If so then why do we still have $70 million at hand. Anyone please chime in.
1 · Reply
Crcarlson8456
Crcarlson8456 Feb. 24 at 2:14 AM
$IXHL no predictions of this or that blah blah blah. Waiting on the news from fda for both drugs that’s it. Anything else is a bonus. Any day now…. Maybe tomorrow maybe 3 weeks from now. Be interesting to see how the market reacts.
0 · Reply
RollTheDice369
RollTheDice369 Feb. 24 at 2:12 AM
$IXHL Today we talked about Joel's lack of communication. We have our opinions, but we can talk about it, which is great. This presentation reminded me of the CGTX presentation where people were waiting to see if the company would get BTD status. The CEO did not inform investors, but in a similar presentation he wrote in small print that the FDA had not granted it to them. LMAO @Santa_Claus_Trades
1 · Reply
RhinoResurrected
RhinoResurrected Feb. 24 at 2:05 AM
$IXHL well then I'm glad i picked up more before close!
0 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 2:02 AM
$IXHL call me stupid but it looks like P2/3 dosing on 560 patients started in may 2024. Are we just waiting for results of P3.
3 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 1:43 AM
$IXHL bulls i went to IXHL website and this is what i found P2/3 dosing on 560 patient started in May 2024 and on the bottom it said P2 data completed July 2025. I’m confuse I thought they haven’t got the patient yet or having dose any patients yet for P3. Can someone explain please. Anyone
2 · Reply
Michaelthoaicaonguyen
Michaelthoaicaonguyen Feb. 24 at 1:10 AM
$IXHL good evening bulls I’ve got a 12 hours shift work today just got out. Did i missed this Is this new👇. Thank you very much.
1 · Reply
diagio
diagio Feb. 24 at 1:00 AM
$AMC $HOLO $NIO $GNS $IXHL Once again whenever you see words like “manipulation, naked shorts, synthetics, shills, hedgies, FTD, CTB, MM suppression, paid basher, paid bot, dark pools” or any other assorted baggie babble or pumper mumbo jumbo... it’s a clear sign the stock is a loser.
3 · Reply
Affen
Affen Feb. 24 at 12:57 AM
$IXHL I couldn't help but notice they highlighted the August 25 date that both psx and ihl had positive results reported. Make me very hopeful of getting eop2 8k for both trials simultaneously
1 · Reply
Rasputi
Rasputi Feb. 24 at 12:52 AM
$IXHL this latest company presentation was requested by the buyer. It will help Resmed shareholders to understand why they paid 10B$ for our drugs portfolio.
0 · Reply
Barracuda_snile
Barracuda_snile Feb. 24 at 12:25 AM
$IXHL Random question... are the paid bashers allowed to invest in the company they're hired to troll on these forums ?
2 · Reply
diagio
diagio Feb. 24 at 12:21 AM
$AMC $HOLO $BURU $IXHL $GNS As you look at what's left of your decimated portfolios it’s just and right that you suffer. You had every warning from reputable traders and top bears, but you wanted to be goofballs and listen to delusional pumpers instead.
2 · Reply
Nawaf643
Nawaf643 Feb. 24 at 12:09 AM
Bet placed. 9 TDs. Material PR on $IXHL by Mar 6 EOD — or I shut this acct down. No inside info. Just my own read between the lines. Bookmark it.
3 · Reply
Barracuda_snile
Barracuda_snile Feb. 24 at 12:05 AM
$IXHL I'm confused, what silence ?? They've been dropping 8-ks for several months... People feed the "Silence" in a positive light 1 week, then switch it too a negative perspective the next. I have to ask myself... How many users on this site are actually investors ??... 25% ?
1 · Reply
nmzl
nmzl Feb. 24 at 12:02 AM
$IXHL One whole package to potential investors.
0 · Reply
trt102967
trt102967 Feb. 23 at 11:39 PM
0 · Reply
Nawaf643
Nawaf643 Feb. 23 at 11:37 PM
$IXHL Lowkey feeling a material PR drops this week 👀🟢
4 · Reply
JackB2025
JackB2025 Feb. 23 at 11:23 PM
$IXHL what the hells going on at Novo? Looks like they could do with a multi billion dollar making pill!!
2 · Reply
Xstof
Xstof Feb. 23 at 11:19 PM
0 · Reply
Seamlessmingler
Seamlessmingler Feb. 23 at 11:15 PM
$IXHL While companies often use "puffery" in marketing, SEC filings are different. Under Section 14(a) of the Securities Exchange Act, it is illegal to include any statement in a proxy filing that is "false or misleading with respect to any material fact."In both the Form PRE 14A (filed October 31, 2024) and the Form DEF 14A (filed December 10, 2025), the official "Management and Corporate Governance" section states: "With over 20 years of experience in both public and private sectors, Mr. Latham leads Incannex’s strategic vision..."The filings explicitly list his age as 36 (as of late 2025). This confirms that the company is formally reporting to the SEC a biography that requires him to have been a "senior" professional since age 16. The Problem: By presenting a 36-year-old as having "20 years of experience" in senior roles, the company risks being accused of materially misleading investors about the "seasoned" nature of its leadership.
2 · Reply